Artificial Intelligence in Cardiovascular Care - Part 2 : Applications: JACC Review Topic of the Week
Copyright © 2024. Published by Elsevier Inc..
Recent Artificial Intelligence (AI) advancements in cardiovascular care offer potential enhancements in effective diagnosis, treatment, and outcomes. Over 600 Food and Drug Administration (FDA)-approved clinical AI algorithms now exist, with 10% focusing on cardiovascular applications, highlighting the growing opportunities for AI to augment care. This review discusses the latest advancements in the field of AI, with a particular focus on the utilization of multimodal inputs and the field of generative AI. Further discussions in this review involve an approach to understanding the larger context in which AI-augmented care may exist, and include a discussion of the need for rigorous evaluation, appropriate infrastructure for deployment, ethics and equity assessments, regulatory oversight, and viable business cases for deployment. Embracing this rapidly evolving technology while setting an appropriately high evaluation benchmark with careful and patient-centered implementation will be crucial for cardiology to leverage AI to enhance patient care and the provider experience.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Journal of the American College of Cardiology - (2024) vom: 26. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jain, Sneha [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 09.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jacc.2024.03.401 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370832825 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370832825 | ||
| 003 | DE-627 | ||
| 005 | 20240410233244.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240410s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jacc.2024.03.401 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM370832825 | ||
| 035 | |a (NLM)38593945 | ||
| 035 | |a (PII)S0735-1097(24)06744-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jain, Sneha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Artificial Intelligence in Cardiovascular Care - Part 2 |b Applications: JACC Review Topic of the Week |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a Recent Artificial Intelligence (AI) advancements in cardiovascular care offer potential enhancements in effective diagnosis, treatment, and outcomes. Over 600 Food and Drug Administration (FDA)-approved clinical AI algorithms now exist, with 10% focusing on cardiovascular applications, highlighting the growing opportunities for AI to augment care. This review discusses the latest advancements in the field of AI, with a particular focus on the utilization of multimodal inputs and the field of generative AI. Further discussions in this review involve an approach to understanding the larger context in which AI-augmented care may exist, and include a discussion of the need for rigorous evaluation, appropriate infrastructure for deployment, ethics and equity assessments, regulatory oversight, and viable business cases for deployment. Embracing this rapidly evolving technology while setting an appropriately high evaluation benchmark with careful and patient-centered implementation will be crucial for cardiology to leverage AI to enhance patient care and the provider experience | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Artificial intelligence | |
| 650 | 4 | |a cardiac imaging | |
| 650 | 4 | |a clinical trials | |
| 650 | 4 | |a deep learning | |
| 650 | 4 | |a digital health | |
| 650 | 4 | |a generative AI | |
| 650 | 4 | |a health equity | |
| 650 | 4 | |a implementation science | |
| 650 | 4 | |a innovation | |
| 650 | 4 | |a large language models | |
| 650 | 4 | |a machine learning | |
| 700 | 1 | |a Elias, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Poterucha, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Randazzo, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez Jimenez, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Khera, Rohan |e verfasserin |4 aut | |
| 700 | 1 | |a Perez, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Ouyang, David |e verfasserin |4 aut | |
| 700 | 1 | |a Pirruccello, James |e verfasserin |4 aut | |
| 700 | 1 | |a Salerno, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Einstein, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Avram, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Tison, Geoff |e verfasserin |4 aut | |
| 700 | 1 | |a Nadkarni, Girish |e verfasserin |4 aut | |
| 700 | 1 | |a Natarajan, Vivek |e verfasserin |4 aut | |
| 700 | 1 | |a Pierson, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Beecy, Ashley |e verfasserin |4 aut | |
| 700 | 1 | |a Kumaraiah, Deepa |e verfasserin |4 aut | |
| 700 | 1 | |a Haggerty, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Avari Silva, Jennifer N |e verfasserin |4 aut | |
| 700 | 1 | |a Maddox, Thomas M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American College of Cardiology |d 1987 |g (2024) vom: 26. März |w (DE-627)NLM012608602 |x 1558-3597 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:26 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacc.2024.03.401 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 26 |c 03 | ||